Aecom vs AstraZeneca plc — how do they compare? Aecom trades at $67.07 (market cap $8.62B), while AstraZeneca plc trades at $158.19 (market cap $248.14B). The key difference: AstraZeneca plc is far larger — about 28.8× Aecom's market cap, and AstraZeneca plc pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| ACM | AZN | |
|---|---|---|
Market Cap | $8.62B | $248.14B |
Sector | Industrials | Health |
52-Week High | $134.35 | $209.48 |
52-Week Low | $66.86 | $147.06 |
Enterprise Value | $10.81B | $275.41B |
Dividend Yield | 1.77% | 2.01% |
Trailing returns across standard periods
Latest headlines on both assets
Aecom is one of the largest global providers of design, engineering, construction, and management services. The firm serves a broad spectrum of end markets including infrastructure, water, transportation, and energy. Based in Los Angeles, Aecom has a presence in over 150 countries and employs 51,000. The company generated $13.3 billion in sales and $701 million in adjusted operating income in fiscal 2021.
Read more on ACM →A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →